The Kabeho Study: Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIV

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1216 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-04-30

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study design includes an observational prospective cohort of HIV-positive pregnant/postpartum women and their infants enrolled during antenatal clinics (or immediately postpartum) from prevention of mother-to-child transmission (PMTCT) programs and followed until the infants reach the age of 18 - 24 months and semi-structure interviews with a sub-set of these women. A second study component involves semi-structured interviews with health care workers (HCW) involved in the PMTCT programs and yearly facility surveys at the selected study facilities.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana

NCT05986084

Pre-Exposure Prophylaxis (PrEP) Breast Feeding

RECRUITING PHASE4

UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study

NCT06158126

Pre-exposure Prophylaxis HIV Prevention Pregnancy Related

RECRUITING PHASE4

Primary HIV Prevention in Pregnant and Lactating Ugandan Women

NCT01882998

Primary Prevention of HIV Acquisition

COMPLETED NA

Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo

NCT03048669

HIV/AIDS Antiretroviral Therapy Pregnancy Outcomes +1 more

COMPLETED NA

Swaziland Safe Generations

NCT01891799

HIV/AIDS

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mother-to-child HIV Transmission

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mothers

HIV Infected mothers

Standard of care

Intervention Type OTHER

Semi-structured interviews

Intervention Type OTHER

Infants

HIV exposed infants

Standard of care

Intervention Type OTHER

Healthcare workers

Facility based healthcare workers

Semi-structured interviews

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard of care

Intervention Type OTHER

Semi-structured interviews

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Documented HIV infection
* Pregnant, in the last trimester of pregnancy or within two weeks post-delivery.
* Participation in the PMTCT program during antenatal care at one of the study sites
* Planning on remaining in the Kigali area after delivery
* Able and willing to give informed consent for study participation for herself and her infant(s).

If a pregnant woman is less than 18 years of age and still living with her parents, informed consent will also be required from one of her parents